Adiponectin levels and its association with hyperglycaemia in adult Filipino participants in the 2003-04 National Nutrition and Health Survey

Diabetes and Vascular Disease Research

Volumn 6, Issue 4, 2009, Pages 231-237

  Paz Pacheco, Elizabeth ^a   Lim Abrahan, Mary Anne ^a   Sy, Rosa Allyn G ^b   Jasul, Gabriel V ^a   Sison, Cherrie Mae C ^a,c   Laurel, Aurora F ^c  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b Cardinal Santos Medical Center   (Philippines)

^c PHILIPPINE GENERAL HOSPITAL   (Philippines)

Author keywords

Adiponectin; Diabetes; Filipino; Hyperglycemia; NNHeS:2003 2004; Prediabetes

Indexed keywords

ADIPONECTIN; GLUCOSE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FASTING; FEMALE; HEALTH SURVEYS; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PHILIPPINES; PREDIABETIC STATE; TIME FACTORS;

EID: 70350168184     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.1177/1479164109344933     Document Type: Article

References (23)

1. Kadowaki T, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792 (Pubitemid 44033298)
2. Kadowaki T, et al. (2005) Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451
3. Ouchi N, et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte derived plasma protein adiponectin. Circulation 100: 2473-2476
4. Ouchi N, et al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301 (Pubitemid 30728130)
5. Arner P (2003) The adipocyte in insulin resistance: key molecules and the impact of thiazolidinediones. Trends Endocrinol Metab 14: 137-145
6. Pajvani UB, Scherer PE (2003) Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep 3: 207-213 (Pubitemid 38906774)
7. Spranger J, et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361: 226-228 (Pubitemid 36126226)
8. Yamauchi T et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-994 (Pubitemid 32756432)
9. Lindsay RS, et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57-58
10. Snehalatha C, et al. (2003) Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26: 3226-3229 (Pubitemid 37466879)
11. Nakashima R, et al. (2006) Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab Epub 1 August as doi:10.1210/jc.2006-1158. (Pubitemid 44536857)
12. Daimon M, et al. (2003) Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: The Funagata study. Diabetes Care 26: 2015-2020 (Pubitemid 41184244)
13. Kim Mi-Jin, et al. (2005) Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus. Yonsei Med J 46(1): 42-50. (Pubitemid 40372871)
14. Duncan BB, et al. (2004) Adiponectin and the development of type 2 diabetes: The Atherosclerosis Risk in Communities Study. Diabetes Care 53: 2473-2478 (Pubitemid 39145606)
15. Araneta MRG, et al. (2007) Adiponectin and ghrelin in normoglycemic Filipino, Caucasian, and African-American women. Obesity 15: 2454-2462
16. Wong C, et al. (2008) Probable NAFLD by ALT levels and diabetes among Filipino-American women. Diabetes Res Clin Pract 79: 133-140
17. Araneta MRG, et al. (2005) Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and White women. Obes Res 13: 1458-1465
18. Dans AL, Morales DD, Velandria F, et al., for the NNHeS: 2003 Group. National Nutrition and Health Survey (NNHeS). (2005) Atherosclerosis-related diseases and risk factors. PhiippJ Intern Med 43: 103-115
19. Matsubara M, Katayose S, Maruoka S (2003) Decrease plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios. Eur J Endocrinol 148: 343-350 (Pubitemid 36410720)
20. Vendramini, et al. (2006) Plasma adiponectin levels and incident glucose intolerance in Japanese-Brazilians: A seven-year follow-up study. Diabetes Res Clin Pract 73:304-309
21. Krakoff J, Funahashi T, da Stehouwer C, et al. (2003) Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26:1745-1751 (Pubitemid 36929114)
22. Weyer C, Funahashi T, Tanaka S, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935 (Pubitemid 32472900)
23. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH (1994) International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B: IV. Comparability of apolipoprotein B values by use of international reference materials. Clin Chem 40: 586-592